Atopic Dermatitis

>

On the HCPLive Atopic Dermatitis condition center page, audiences can find a variety of coverage mediums for medical news and updates, including articles, video interviews, podcasts, and breaking news on dermatitis research, treatment, and drug development.

Latest News

Valerie Jaroenpuntaruk, MD I Credit: the Mayo Clinic
Omalizumab Linked to Greatest Rate of Hypersensitivity Reactions in Atopic Diseases

February 21st 2025

A study analyzed hypersensitivity reactions to biologics for atopic diseases, highlighting reaction types, severity, and biologic discontinuation rates.

Justin Greiwe, MD, Bernstein Allergy Group, and Clinical Assistant Professor of Medicine, Division of Immunology, Allergy, and Rheumatology, University of Cincinnati
Tapinarof Demonstrates Consistent Efficacy Across Body Regions in People With Atopic Dermatitis

February 21st 2025

Pediatric Atopic Dermatitis Most Effectively Treated with Upadacitinib, Study Finds
Pediatric Atopic Dermatitis Most Effectively Treated with Upadacitinib, Study Finds

February 20th 2025

FDA Clears IND Application for Zabalafin Hydrogel Treatment of Atopic Dermatitis
FDA Clears IND Application for Zabalafin Hydrogel Treatment of Atopic Dermatitis

February 20th 2025

Eric Simpson, MD, Frances J. Storrs, M.D. Medical Dermatology Professor, Dermatology, School of Medicine, Oregon Health & Science University
Ruxolitinib Shows Clinical Benefit in Children, Adults With Atopic Dermatitis

February 19th 2025

© 2025 MJH Life Sciences

All rights reserved.